Loss-of-function genomic variants with impact on liver-related blood traits highlight potential therapeutic targets for cardiovascular disease
Jonas Bille Nielsen, Oren Rom, Ida L. Surakka, Sarah E. Graham, Wei Zhou, Lars G. Fritsche, Sarah A. Gagliano Taliun, Carlo Sidore, Yuhao Liu, Maiken Elvestad Gabrielsen, Anne Heidi Skogholt, Brooke N. Wolford, William Overton, Whitney Hornsby, Akua Acheampong, , Y. Eugene Chen
The paper identifies loss-of-function variants affecting liver-related blood traits that reduce CVD risk without increasing metabolic disease risk, highlighting potential therapeutic targets.
bioRxiv · Apr 2, 2019 · PreprintGenomics